TrialBritish journal of haematology2017

Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial.

Jin Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.